← All trials
NCT00733798
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2008
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 58
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- TransMolecularLead sponsor
- Mary Crowley Cancer CenterOverall official - principal investigator
- New York UniversityOverall official - principal investigator
- Mercy Health, Grand RapidsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.